Detection of fentanyl, synthetic opioids, and ketamine in hair specimens from purposive samples of American and Italian populations

Abstract

With the current crisis related to the diffusion of fentanyl and other novel opioids in several countries and populations, new and effective approaches are needed to better elucidate the phenomenon. In this context, hair testing offers a unique perspective in the investigation of drug consumption, producing useful information in terms of exposure to psychoactive substances. In this research, we applied targeted ultra‐high performance liquid chromatography tandem mass spectrometry (UHPLC–MS/MS) analytical methods to detect novel synthetic and prescription opioids and other common controlled psychoactive drugs in the keratin matrix. A total of 120 hair samples were analyzed from the United States (US) and Italy, segmented when longer than 6 cm, and then analyzed. In the 60 samples (83 segments in total) analyzed from a purposive sample of data collected in the US, fentanyl was detected in 14 cases (16.9%), with no detection of nitazens or brorphine. We also detected fentanyl metabolites, despropionyl‐p‐fluorofentanyl, and prescription opioids. In the 60 samples collected in Italy (91 segments in total), ketamine was the most prevalent compound detected (in 41 cases; 45.1%), with ketamine demonstrating a strong correlation with detection of amphetamines and MDMA, likely due to co‐use of these substances in recreational contexts. Several common drugs were also detected but no exposure to fentanyl or its analogs were detected. Results of this retrospective exploration of drug use add to increasing evidence that hair testing can serve as a useful adjunct to epidemiology studies that seek to determine biologically confirmed use and exposure in high‐risk populations.

Introduction to the JFS Special Section on Fentanyl and its Analogs in Forensic Science

“…The final articles are on forensic pathology and forensic toxicology [13][14][15][16][17][18][19]. There is a Case Report [20] that serves as a path forward in the detection of "fentanyls," other novel synthetic opioids (NSO), and novel psychoactive substances (NPS).…”